nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Ill-defined disorder—Etoposide—testicular cancer	0.00167	0.00167	CcSEcCtD
Gadodiamide—Anxiety—Cisplatin—testicular cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Dyspnoea—Ifosfamide—testicular cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Somnolence—Ifosfamide—testicular cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Discomfort—Cisplatin—testicular cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Vomiting—Vinblastine—testicular cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Malaise—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Gadodiamide—Headache—Vinblastine—testicular cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Fatigue—Ifosfamide—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Oedema—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Anaphylactic shock—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Hypersensitivity—Bleomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Infection—Cisplatin—testicular cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Pain—Ifosfamide—testicular cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Gadodiamide—Nervous system disorder—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Gadodiamide—Tachycardia—Cisplatin—testicular cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Asthenia—Bleomycin—testicular cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Hyperhidrosis—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Gadodiamide—Pruritus—Bleomycin—testicular cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Feeling abnormal—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—testicular cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Nausea—Vinblastine—testicular cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Hypotension—Cisplatin—testicular cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—testicular cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Urticaria—Ifosfamide—testicular cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Abdominal pain—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Body temperature increased—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Infection—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—testicular cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Paraesthesia—Cisplatin—testicular cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—testicular cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Dyspnoea—Cisplatin—testicular cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—testicular cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Vomiting—Bleomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—testicular cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Rash—Bleomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Pain—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Dermatitis—Bleomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Hypersensitivity—Ifosfamide—testicular cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Asthenia—Ifosfamide—testicular cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Feeling abnormal—Cisplatin—testicular cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Pruritus—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Nausea—Bleomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Diarrhoea—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Body temperature increased—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Pain—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Dizziness—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—testicular cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—testicular cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Vomiting—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Hypersensitivity—Cisplatin—testicular cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Rash—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Dermatitis—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Asthenia—Cisplatin—testicular cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Chills—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Nausea—Ifosfamide—testicular cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Diarrhoea—Cisplatin—testicular cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Chills—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Vomiting—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Rash—Cisplatin—testicular cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Dermatitis—Cisplatin—testicular cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—testicular cancer	0.000999	0.000999	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—testicular cancer	0.000999	0.000999	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—testicular cancer	0.000994	0.000994	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—testicular cancer	0.000987	0.000987	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—testicular cancer	0.000971	0.000971	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—testicular cancer	0.00097	0.00097	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—testicular cancer	0.000961	0.000961	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—testicular cancer	0.000957	0.000957	CcSEcCtD
Gadodiamide—Nausea—Cisplatin—testicular cancer	0.000951	0.000951	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—testicular cancer	0.000935	0.000935	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—testicular cancer	0.000933	0.000933	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—testicular cancer	0.000933	0.000933	CcSEcCtD
Gadodiamide—Rash—Etoposide—testicular cancer	0.000925	0.000925	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—testicular cancer	0.000924	0.000924	CcSEcCtD
Gadodiamide—Headache—Etoposide—testicular cancer	0.000919	0.000919	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—testicular cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—testicular cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—testicular cancer	0.000917	0.000917	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—testicular cancer	0.000909	0.000909	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—testicular cancer	0.000906	0.000906	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—testicular cancer	0.000904	0.000904	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—testicular cancer	0.000886	0.000886	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—testicular cancer	0.000879	0.000879	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—testicular cancer	0.000873	0.000873	CcSEcCtD
Gadodiamide—Infection—Methotrexate—testicular cancer	0.000873	0.000873	CcSEcCtD
Gadodiamide—Nausea—Etoposide—testicular cancer	0.000871	0.000871	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000865	0.000865	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—testicular cancer	0.000862	0.000862	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—testicular cancer	0.000858	0.000858	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—testicular cancer	0.000858	0.000858	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—testicular cancer	0.000858	0.000858	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—testicular cancer	0.000855	0.000855	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—testicular cancer	0.00085	0.00085	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—testicular cancer	0.000848	0.000848	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—testicular cancer	0.000841	0.000841	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—testicular cancer	0.000839	0.000839	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—testicular cancer	0.000822	0.000822	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—testicular cancer	0.000822	0.000822	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—testicular cancer	0.000821	0.000821	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—testicular cancer	0.000819	0.000819	CcSEcCtD
Gadodiamide—Infection—Epirubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Gadodiamide—Shock—Epirubicin—testicular cancer	0.000809	0.000809	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—testicular cancer	0.000806	0.000806	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000801	0.000801	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—testicular cancer	0.000789	0.000789	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—testicular cancer	0.000784	0.000784	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—testicular cancer	0.000783	0.000783	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—testicular cancer	0.000781	0.000781	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—testicular cancer	0.000776	0.000776	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—testicular cancer	0.000774	0.000774	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—testicular cancer	0.000768	0.000768	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—testicular cancer	0.000758	0.000758	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Gadodiamide—Pain—Methotrexate—testicular cancer	0.000751	0.000751	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—testicular cancer	0.000746	0.000746	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000736	0.000736	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—testicular cancer	0.000731	0.000731	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—testicular cancer	0.000724	0.000724	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—testicular cancer	0.000724	0.000724	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000719	0.000719	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—testicular cancer	0.000709	0.000709	CcSEcCtD
Gadodiamide—Pain—Epirubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—testicular cancer	0.000698	0.000698	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—testicular cancer	0.000695	0.000695	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—testicular cancer	0.000695	0.000695	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—testicular cancer	0.000678	0.000678	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—testicular cancer	0.000678	0.000678	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000672	0.000672	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—testicular cancer	0.00067	0.00067	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—testicular cancer	0.000656	0.000656	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—testicular cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—testicular cancer	0.000647	0.000647	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—testicular cancer	0.000631	0.000631	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000627	0.000627	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000622	0.000622	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—testicular cancer	0.000622	0.000622	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—testicular cancer	0.000605	0.000605	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—testicular cancer	0.000601	0.000601	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—testicular cancer	0.00059	0.00059	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—testicular cancer	0.000581	0.000581	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—testicular cancer	0.000563	0.000563	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—testicular cancer	0.000559	0.000559	CcSEcCtD
Gadodiamide—Rash—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Gadodiamide—Headache—Methotrexate—testicular cancer	0.000551	0.000551	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—testicular cancer	0.000544	0.000544	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—testicular cancer	0.000522	0.000522	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
Gadodiamide—Rash—Epirubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Gadodiamide—Headache—Epirubicin—testicular cancer	0.000515	0.000515	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—testicular cancer	0.000503	0.000503	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—testicular cancer	0.00048	0.00048	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—testicular cancer	0.000477	0.000477	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
